sur Biophytis (EPA:ALBPS)
Biophytis and LynxKite Feature at NVIDIA GTC Conference
Biophytis SA and LynxKite Technologies participated in the NVIDIA GTC conference, a prominent event in artificial intelligence and accelerated computing. Held from March 16 to 19, 2026, this gathering attracted over 25,000 attendees and featured 1,000 sessions led by tech leaders and global companies.
The conference showcased AI advancements, including updates to the AlphaFold Database and the unveiling of Proteina-Complexa. Biophytis, collaborating with LynxKite and Nebius, presented its AI-driven platform aimed at boosting drug discovery in the longevity market, valued at $1.5 trillion.
Biophytis also engaged with investors and partners, and demonstrated BIO101, their lead drug candidate. CEO Stanislas Veillet highlighted the company's commitment to leveraging AI for innovations in longevity.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Biophytis